Gene Expression Profiling in Brodmann's Area 46 from Subjects with Schizophrenia

Objective: To identify altered gene expression in the dorsolateral prefrontal cortex obtained after death from subjects with schizophrenia. Method: Restriction fragment differential display (RFDD) was used to measure levels of mRNA in Brodmann area (BA) 46 from schizophrenia and control subjects. Findings on specific mRNA identified with RFDD were further investigated using real-time polymerase chain reaction (real-time PCR), PCR and western blotting. Results: Levels of mRNA for 63 of approximately 12 500 genes differed in BA 46 in schizophrenia. Subsequent real-time PCR has shown that mRNA for muscleblind protein 1 (MBNL1) and protocadherin 17 (PCDH17) are increased in BA 46 from subjects with schizophrenia of short, but not long, duration. Altered levels of mRNA for neither gene were present in BA 9 from subjects with schizophrenia or in either cortical area from subjects with bipolar 1 disorder. By contrast, both RFDD and real-time PCR failed to show altered expression of the schizophrenia candidate gene disrupted in schizophrenia 1 (DISC1) BA46 from any diagnostic cohort. Conclusion: The present study has identified genes that are differentially expressed in BA 46 in schizophrenia. Initial studies have shown that there is a need for a careful validation of genes shown to be affected in schizophrenia using high-throughput technologies. In addition the present study has shown that gene expression may vary considerably depending on the duration of schizophrenia. This raises the hypothesis that changing gene expression may be underlying the change in symptom profile that occurs with disease progression in some subjects with schizophrenia.

[1]  B. Dean,et al.  Understanding the Pathology of Schizophrenia: The Impact of High- Throughput Screening of the Genome and Proteome in Postmortem CNS , 2005 .

[2]  M. Harrow,et al.  A prospective longitudinal 10-year study of schizophrenia's three major factors and depression , 2000, Psychiatry Research.

[3]  M. Tsuang.  Schizophrenia: genes and environment , 2000, Biological Psychiatry.

[4]  H. Meltzer,et al.  Brain and skeletal muscle monoamine oxidase activity in schizophrenia. , 1980, Schizophrenia bulletin.

[5]  A. Mackinnon,et al.  Problem of diagnosis in postmortem brain studies of schizophrenia. , 1996, The American journal of psychiatry.

[6]  D. Lewis,et al.  Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.

[7]  Daniel R Weinberger,et al.  Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. , 2006, Human molecular genetics.

[8]  Paul J. Harrison,et al.  Schizophrenia: a genetic disorder of the synapse? , 2005, BMJ : British Medical Journal.

[9]  M. Webster,et al.  Application of cDNA microarrays to examine gene expression differences in schizophrenia , 2001, Brain Research Bulletin.

[10]  Elmar Wahle,et al.  Messenger RNA Turnover in Eukaryotes: Pathways and Enzymes , 2004, Critical reviews in biochemistry and molecular biology.

[11]  H. Meltzer.  Cognitive Factors in Schizophrenia: Causes, Impact, and Treatment , 2004, CNS Spectrums.

[12]  Kazuya Iwamoto,et al.  Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. , 2005, Human molecular genetics.

[13]  J. Waddington,et al.  Longitudinal assessment of psychopathological domains over late-stage schizophrenia in relation to duration of initially untreated psychosis: 3-year prospective study in a long-term inpatient population , 2004, Psychiatry Research.

[14]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Hauswirth,et al.  A Muscleblind Knockout Model for Myotonic Dystrophy , 2003, Science.

[16]  Martin S. Taylor,et al.  Disruption of two novel genes by a translocation co-segregating with schizophrenia. , 2000, Human molecular genetics.

[17]  A. Sampson,et al.  Gene Expression Deficits in a Subclass of GABA Neurons in the Prefrontal Cortex of Subjects with Schizophrenia , 2003, The Journal of Neuroscience.

[18]  P. McGuffin,et al.  Linkage and associated studies of schizophrenia. , 2000, American journal of medical genetics.

[19]  H. Hwu,et al.  A Single Nucleotide Polymorphism Fine Mapping Study of Chromosome 1q42.1 Reveals the Vulnerability Genes for Schizophrenia, GNPAT and DISC1: Association with Impairment of Sustained Attention , 2006, Biological Psychiatry.

[20]  Peter B. Jones,et al.  Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Yolken,et al.  The Stanley Foundation brain collection and Neuropathology Consortium , 2000, Schizophrenia Research.

[22]  Rajiv P. Sharma.  Schizophrenia, epigenetics and ligand-activated nuclear receptors: a framework for chromatin therapeutics , 2004, Schizophrenia Research.

[23]  B. Lipska,et al.  Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus , 2006, Journal of Neural Transmission.

[24]  J. Trojanowski,et al.  Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. , 2002, Archives of general psychiatry.

[25]  Daniel R Weinberger,et al.  Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study , 2002, Schizophrenia Research.

[26]  B. Dean.  Signal Transmission, Rather Than Reception, is the Underlying Neurochemical Abnormality in Schizophrenia , 2000, The Australian and New Zealand journal of psychiatry.

[27]  T. Cooper,et al.  Muscleblind proteins regulate alternative splicing , 2004, The EMBO journal.

[28]  A Prokop,et al.  The muscleblind gene participates in the organization of Z-bands and epidermal attachments of Drosophila muscles and is regulated by Dmef2. , 1998, Developmental biology.

[29]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[30]  Vincent Magnotta,et al.  Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia. , 2003, Archives of general psychiatry.

[31]  C D Marsden,et al.  Tissue pH as an indicator of mRNA preservation in human post-mortem brain. , 1995, Brain research. Molecular brain research.

[32]  Sarah A. J. Reading,et al.  Neurobiology of Schizophrenia , 2006, Neuron.

[33]  Daniel R. Weinberger,et al.  Schizophrenia and the frontal lobe , 1988, Trends in Neurosciences.

[34]  D. Blackwood,et al.  Identification of polymorphisms within Disrupted in Schizophrenia 1 and Disrupted in Schizophrenia 2, and an investigation of their association with schizophrenia and bipolar affective disorder , 2001, Psychiatric genetics.

[35]  K O Lim,et al.  Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study. , 2001, Archives of general psychiatry.

[36]  C. Angelini,et al.  Cognitive impairment and (CTG)n expansion in myotonic dystrophy patients , 1999, Biological Psychiatry.

[37]  S. Brenner,et al.  Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Redies,et al.  delta-Protocadherins: unique structures and functions. , 2005, Cellular and molecular life sciences : CMLS.

[39]  N. Wray,et al.  Association between the TRAX/DISC locus and both bipolar disorder and schizophrenia in the Scottish population , 2005, Molecular Psychiatry.

[40]  J. Sutcliffe,et al.  Open-System Approaches to Gene Expression in the CNS , 2001, The Journal of Neuroscience.

[41]  D. G. Standaert,et al.  Gene expression profiling in the post-mortem human brain — no cause for dismay , 2001, Journal of Chemical Neuroanatomy.

[42]  J. Lauriello,et al.  Longitudinal follow-up of neurochemical changes during the first year of antipsychotic treatment in schizophrenia patients with minimal previous medication exposure , 2002, Schizophrenia Research.

[43]  R Freedman,et al.  Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. , 2005, Brain research. Molecular brain research.

[44]  Peter B. Jones,et al.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.

[45]  T. McGlashan,et al.  Treatment of schizophrenia , 1995, The Lancet.

[46]  Andrew L. Lemire,et al.  Deficient Hippocampal Neuron Expression of Proteasome, Ubiquitin, and Mitochondrial Genes in Multiple Schizophrenia Cohorts , 2005, Biological Psychiatry.

[47]  Feng Zhang,et al.  Genetic association between schizophrenia and the DISC1 gene in the Scottish population , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[48]  R. Kemler,et al.  Mammalian cadherins and protocadherins: about cell death, synapses and processing. , 2005, Current opinion in cell biology.

[49]  R. Teasdale,et al.  Genes induced by growth hormone in a model of adipogenic differentiation , 2002, Molecular and Cellular Endocrinology.

[50]  I. Kiss,et al.  muscleblind, a gene required for photoreceptor differentiation in Drosophila, encodes novel nuclear Cys3His-type zinc-finger-containing proteins. , 1997, Development.

[51]  C. Redies,et al.  δ-Protocadherins: unique structures and functions , 2005, Cellular and Molecular Life Sciences CMLS.

[52]  J. Pierri,et al.  Gene Expression Profiling Reveals Alterations of Specific Metabolic Pathways in Schizophrenia , 2002, The Journal of Neuroscience.

[53]  Takashi Akasaka,et al.  BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. , 2003, Blood.

[54]  W Hennah,et al.  Replication of 1q42 linkage in Finnish schizophrenia pedigrees , 2004, Molecular Psychiatry.

[55]  R. Straub,et al.  Expression of DISC 1 binding partners is reduced in schizophrenia and associated with DISC 1 SNPs , 2006 .